Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

Journey Medical to Join Russell 2000® and Russell 3000® Indexes